Google Play icon

Research note: Study uncovers marker for a chronic brain disease

Share
Posted August 23, 2016

A team of researchers led by Yale professor of pathology Wang Min have pinpointed a marker that contributes to a chronic condition affecting the brain.

Diseased mice treated with mock (left) or angiopoietin-2-neutralizing antibody (right). The antibody blunts cerebral cavernous malformation progression.

Diseased mice treated with mock (left) or angiopoietin-2-neutralizing antibody (right). The antibody blunts cerebral cavernous malformation progression.

Known as cerebral cavernous malformations, the condition is characterized by a tangle of capillaries in the brain’s white matter, which can cause headaches, seizures, bleeding, and even death. No effective therapy exists. (It has been reported that Olympic runner Florence Griffith Joyner, who died suddenly in 1998, had this condition.) Using an animal model of the disease, Min and his co-authors identified a growth factor (angioproetin-2) that when blocked by an antibody, eliminates the malformations. “We have discovered a new and effective therapy for this potentially debilitating disorder,” he noted.

The study was published August 22 in Nature Medicine.

Source: Yale University

Featured news from related categories:



Technology Org App
Google Play icon
85,505 science & technology articles

Most Popular Articles

  1. New treatment may reverse celiac disease (October 22, 2019)
  2. The World's Energy Storage Powerhouse (November 1, 2019)
  3. "Helical Engine" Proposed by NASA Engineer could Reach 99% the Speed of Light. But could it, really? (October 17, 2019)
  4. Plastic waste may be headed for the microwave (October 18, 2019)
  5. Universe is a Sphere and Not Flat After All According to a New Research (November 7, 2019)

Follow us

Facebook   Twitter   Pinterest   Tumblr   RSS   Newsletter via Email